L&C Bio shares surged following plans to develop a human-fat injection that addresses facial volume loss caused by weight-loss drugs like Ozempic.SummarySubscribe to TodayOnChain membership to read full news summaries and browse without display ads.
Is crypto dead yet? Project shutdowns peaked this April but the latest 2026 data hides a scarier trend
Coinbase launches 24/5 US stock trading for UK users, advancing ‘Everything Exchange’ strategy
Bitcoin-backed loan refinances PowerCompute’s $18M debt at 2%
L&C Bio’s Human-Fat Injection Could Fix “Ozempic Face”: Will Gains Hold?
Live updates: Bitcoin nears $65,000 as oil, inflation hopes keep macro bid alive
Bitcoin developers flag 85 critical bugs in an "extremely bad" situation
Bitcoin ETFs pull in $244M, 3-day inflow streak tops $626M
Japanese stablecoin firm JPYC raises $38 million in extended Series B
Galaxy Digital Stock Slides 14% as Crypto Prices Hit Earnings
S&P 500 has added crypto's $2 trillion market cap this month. Bitcoin is not impressed. Here's why
